Andrew Steinsapir

Company: Apertura Gene Therapy

Job title: Acting Chief Technology Officer

Seminars:

Discussing Changing Regulatory Guidelines to Perfect Regulatory Submissions & Receive Quick Approvals 1:30 pm

With the evolving regulatory landscape and changing leadership, regulatory uncertainty is at an all-time high. When it comes to gene therapies for the CNS, there are key regulatory expectations such as safety, biodistribution, long-term follow up, efficacy, delivery methods, and more that need to be met. Working to get IND clearance and reach clinical trials…Read more

day: Pre-Conference Day